Market Tracker

09/30 2:40pm ET

GenMark Diagnostics Inc (NASDAQ:GNMK)

11.90
BATS BZX Real-Time Price
As of 2:40pm ET
 +1.02 / +9.37%
Today’s Change
4.20
Today|||52-Week Range
12.17
+53.35%
Year-to-Date
GenMark Diagnostics Hits 52-Week High on Solid Prospects
Sep 28 / Zacks.com - Paid Partner Content
Why GenMark Diagnostics, Inc. Is Soaring Today
Sep 16 / MotleyFool.com - Paid Partner Content
Can the Rally in GenMark Diagnostics (GNMK) Shares Continue?
Sep 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close10.88
Today’s open11.00
Day’s range10.89 - 11.93
Volume12,100
Average volume (3 months)310,742
Market cap$467.8M
Dividend yield--
Data as of 2:40pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-17.86%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+28.82%
P/E ratioNM
Price/Sales8.30
Price/Book9.53

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc+0.26+1.67%
OSUROraSure Technologies...-0.01-0.13%
ATRCAtriCure Inc+0.34+2.21%
BEATBioTelemetry Inc+0.31+1.68%
Data as of 2:39pm ET, 09/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$39.4M
Annual profit (last year)-$42.2M
Net profit margin-107.07%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Chief Financial Officer
Scott Mendel
Corporate headquarters
Carlsbad, California

Forecasts